Mitochondrial alterations during carcinogenesis: a review of metabolic transformation and targets for anticancer treatments
- PMID: 23870511
- DOI: 10.1016/B978-0-12-407190-2.00004-6
Mitochondrial alterations during carcinogenesis: a review of metabolic transformation and targets for anticancer treatments
Abstract
Mitochondria play important roles in multiple cellular processes including energy metabolism, cell death, and aging. Regulated energy production and utilization are critical in maintaining energy homeostasis in normal cells and functional organs. However, mitochondria go through a series of morphological and functional alterations during carcinogenesis. The metabolic profile in transformed cells is altered to accommodate their fast proliferation, confer resistance to cell death, or facilitate metastasis. These transformations also provide targets for anticancer treatment at different levels. In this review, we discuss the major modifications in cell metabolism during carcinogenesis, including energy metabolism, apoptotic and autophagic cell death, adaptation of tumor microenvironment, and metastasis. We also summarize some of the main metabolic targets for treatments.
Keywords: HIF1; Hypoxia; Microenvironment; Mitochondria; ROS; Respiration; Warburg; mtDNA.
Copyright © 2013 Elsevier Inc. All rights reserved.
Similar articles
-
Mitochondria in cancer cells: what is so special about them?Trends Cell Biol. 2008 Apr;18(4):165-73. doi: 10.1016/j.tcb.2008.01.006. Epub 2008 Mar 4. Trends Cell Biol. 2008. PMID: 18296052 Review.
-
The causes of cancer revisited: "mitochondrial malignancy" and ROS-induced oncogenic transformation - why mitochondria are targets for cancer therapy.Mol Aspects Med. 2010 Apr;31(2):145-70. doi: 10.1016/j.mam.2010.02.008. Epub 2010 Mar 2. Mol Aspects Med. 2010. PMID: 20206201 Review.
-
Hypoxia-mediated drug resistance: novel insights on the functional interaction of HIFs and cell death pathways.Drug Resist Updat. 2011 Jun;14(3):191-201. doi: 10.1016/j.drup.2011.03.001. Epub 2011 Apr 3. Drug Resist Updat. 2011. PMID: 21466972 Review.
-
Mitochondria and cancer chemoresistance.Biochim Biophys Acta Bioenerg. 2017 Aug;1858(8):686-699. doi: 10.1016/j.bbabio.2017.01.012. Epub 2017 Feb 1. Biochim Biophys Acta Bioenerg. 2017. PMID: 28161329 Review.
-
The crosstalk between HIFs and mitochondrial dysfunctions in cancer development.Cell Death Dis. 2021 Feb 26;12(2):215. doi: 10.1038/s41419-021-03505-1. Cell Death Dis. 2021. PMID: 33637686 Free PMC article. Review.
Cited by
-
Panoramic view of key cross-talks underpinning the oral squamous cell carcinoma stemness - unearthing the future opportunities.Front Oncol. 2023 Dec 19;13:1247399. doi: 10.3389/fonc.2023.1247399. eCollection 2023. Front Oncol. 2023. PMID: 38170015 Free PMC article. Review.
-
Cellular metabolic energy modulation by tangeretin in 7,12-dimethylbenz(a) anthracene-induced breast cancer.J Biomed Res. 2016 Mar;30(2):134-141. doi: 10.7555/JBR.30.20150060. Epub 2016 Feb 26. J Biomed Res. 2016. PMID: 28276668 Free PMC article.
-
Caffeic acid phenethyl ester (CAPE) possesses pro-hypoxia and anti-stress activities: bioinformatics and experimental evidences.Cell Stress Chaperones. 2018 Sep;23(5):1055-1068. doi: 10.1007/s12192-018-0915-0. Epub 2018 Jun 4. Cell Stress Chaperones. 2018. PMID: 29869000 Free PMC article.
-
Enhanced Photodynamic Cancer Treatment by Mitochondria-Targeting and Brominated Near-Infrared Fluorophores.Adv Sci (Weinh). 2017 Dec 19;5(3):1700481. doi: 10.1002/advs.201700481. eCollection 2018 Mar. Adv Sci (Weinh). 2017. PMID: 29593951 Free PMC article.
-
Recent advances in photodynamic therapy for cancer and infectious diseases.Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2019 Sep;11(5):e1560. doi: 10.1002/wnan.1560. Epub 2019 May 6. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2019. PMID: 31058443 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources